<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8" />
    <meta name="viewport" content="width=device-width, initial-scale=1.0" />
    <meta http-equiv="X-UA-Compatible" content="ie=edge" />
    <link
        href="https://fonts.googleapis.com/css2?family=Lato:wght@100;300;400&family=Roboto:wght@100;300;500&display=swap"
        rel="stylesheet" />
    <link rel="stylesheet" href="css/style.css" />
    <title>ID Pharma</title>
</head>

<body>

    
        <div class="container" id="en">
            <nav class="navbar">
                <div class="navbar-logo-home">
                    <a href="#" class="logo-image">
                        <div class="navbar-logo"></div>
                    </a>
                </div>
                <div class="navbar-buttons">
                    <ul class="menu-list">
                        <li class="list-element">
                            <a href="#about-en" class="link">about us</a>
                        </li>
                        <li class="list-element nav-offer">
                            <a href="#offer-1-en" class="link">offer</a>
                            <div class="dropdown-menu">
                                <div class="button-border">
                                    <a href="#offer-1-en" class="dropdown-item">PHARMACOVIGILANCE</a>
                                </div>
                                <div class="button-border">
                                    <a href="#offer-2-en" class="dropdown-item">AUDITS</a>
                                </div>
                                <div class="button-border">
                                    <a href="#offer-3-en" class="dropdown-item">MEDICAL INFORMATION</a>
                                </div>
                                <div class="button-border">
                                    <a href="#offer-4-en" class="dropdown-item">Local Contact Person in Poland and in
                                        other
                                        countries</a>
                                </div>
                                <div class="button-border">
                                    <a href="#offer-5-en" class="dropdown-item">Cosmetovigilance</a>
                                </div>
                                <div class="button-border">
                                    <a href="#offer-6-en" class="dropdown-item">Registration of medicinal products</a>
                                </div>
                            </div>
                        </li>
                        <li class="list-element">
                            <a href="#contact-en" class="link">contact</a>
                        </li>
                        <li class="list-element">
                            <a href="index.html" class="link link-lg link-lg-pl" id="language">PL</a>
                        </li>

                        <li class="list-element">
                            <a href="index-en.html" class="link link-lg">EN</a>
                        </li>
                    </ul>
                </div>
            </nav>
            <section class="about-1">
                <a class="anchor" id="about-en"></a>
                <div class="about-1-1">
                    <h3>
                        <strong>ID Pharma</strong> is a partnership established by qualified consultants each having
                        over
                        twenty years of experience in the pharmaceutical sector in the fields of: medicinal products
                        registration,
                        pharmacovigilance and cosmetovigilance, as well as medical support for marketing divisions.
                    </h3>
                    <h4>
                        Our consultants have an extensive knowledge, confirmed competences and significant achievements
                        in building and implementing quality systems required for pharmacovigilance and medical
                        information.
                        They also have broad experience in aspects of regulatory affairs and preparation
                        of documentation required for the above mentioned process.
                        When providing services, our consultants assure compliance with national and supranational legal
                        requirements.
                    </h4>
                </div>
                <div class="about-1-2"></div>
            </section>
            <section class="anchor about-2">
                <a class="anchor" id="about-2-en"></a>
                <div class="about-2-1">
                    <h2>OUR PARTNERSHIP SPECIALIZES IN:</h2>
                    <ul>
                        <li>
                            <h4>
                                preparation, update and development of quality systems allowing due
                                and compliant with legal regulations conduct of pharmacovigilance;
                            </h4>
                        </li>
                        <li>
                            <h4>
                                auditing of pharmacovigilance systems;
                            </h4>
                        </li>
                        <li>
                            <h4>
                                supervision over the safety of the use of cosmetic products: Cosmetovigilance;
                            </h4>
                        </li>
                        <li>
                            <h4>
                                preparation of strategy and development of products / support in conduct of registration
                                processes;
                            </h4>
                        </li>
                    </ul>

                </div>
                <div class="about-2-2">
                    <h2>OUR SERVICES:</h2>
                    <h3>
                        We are here for our Clients to provide them with our support through
                        our knowledge and experience in order to develop their medicinal products
                        and borderline products (cosmetics, dietary supplements and medical devices).
                        We support pharmaceutical companies in due conduct of pharmacovigilance
                        as well as supervision over the use of cosmetics and medical devices.
                    </h3>
                </div>
            </section>
            <section class="offer-1">
                <a class="anchor" id="offer-1-en"></a>
                <div class="offer-title">
                    <h2>PHARMACOVIGILANCE</h2>
                </div>
                <div class="offer-content">
                    <h3>
                        ID Pharma has its own Pharmacovigilance system described with
                        PSMF as well as a qualified person responsible for pharmacovigilance
                        (QPPV) and her deputy (Deputy QPPV), which opens opportunities for:
                    </h3>
                    <h3>
                        Registration of medicinal products using the pharmacovigilance system
                        and the qualified person responsible for pharmacovigilance (QPPV) provided by ID Pharma;
                    </h3>
                    <h3>
                        Taking over of the obligations of the MAH in the field of pharmacovigilance
                        in the period during and after product authorization (fully or partially), including:
                    </h3>

                    <ul>
                        <li>
                            <h4>
                                registration in the EudraVigilance system (ID Pharma possesses appropriate user
                                certificates);
                            </h4>
                        </li>
                        <li>
                            <h4>
                                preparation of selected procedures describing pharmacovigilance activities
                                or a set of procedures in line with the processes required in pharmacovigilance;
                            </h4>
                        </li>
                        <li>
                            <h4>
                                preparation of a complete description of the adverse drug reaction monitoring system
                                (PSMF) tailored to the needs of the company and a summary description (SPS) required in
                                the
                                registration processes;
                            </h4>
                        </li>
                        <li>
                            <h4>
                                preparation of xEVMPD (extended Eudravigilance Medicinal Product Dictionary - in
                                accordance
                                with Article 57(2) of Regulation (EC) No. 726/2004
                            </h4>
                        </li>
                        <li>
                            <h4>
                                risk analysis of the implemented pharmacovigilance system and its adjustment to the
                                structure of organization and legal requirements;
                            </h4>
                        </li>
                        <li>
                            <h4>
                                preparing the company for the Pharmacovigilance inspection;
                            </h4>
                        </li>
                        <li>
                            <h4>
                                management of observations / deficiency after the inspection (CAPA preparation according
                                to
                                the "Deficiency Letters");
                            </h4>
                        </li>
                        <li>
                            <h4>
                                preparation of documentation: periodic reports, RMP with risk minimization, Clinical
                                Expert
                                Statement, Addendum to the Clinical Overview;
                            </h4>
                        </li>
                        <li>
                            <h4>
                                preparation of a risk minimization proposal;
                            </h4>
                        </li>

                        <li>
                            <h4>
                                we ensure 24-hour accessibility in order to report adverse drug reaction;
                            </h4>
                        </li>
                        <li>
                            <h4>
                                processing of adverse drug reaction reports including medical evaluation;
                            </h4>
                        </li>
                        <li>
                            <h4>
                                pharmacovigilance system audits.
                            </h4>
                        </li>
                    </ul>
                </div>
            </section>
            <section class="offer-2">
                <a class="anchor" id="offer-2-en"></a>
                <div class="offer-title">
                    <h2>AUDITS</h2>
                    <h2>in the area of the pharmacovigilance system:</h2>
                </div>
                <div class="offer-content">
                    <h3>
                        Audit in the area of the pharmacovigilance system
                        is the responsibility of Marketing Authorization Holder.
                    </h3>
                    <h3>
                        Pursuant to Directive 2001/83 / EC Art 101 (2), Art 104 (2), Regulation No 726/2004
                        Art 28f and the guidelines of Good Pharmacovigilance Practice (GVP), audits should
                        be carried out regularly in accordance with the prepared audit plan and based on the
                        risk analysis. Regulation (EU) No 520/2012 Art 13 (1), Art 17 (1).
                    </h3>
                    <h3>
                        The consultants / auditors possess years of experience in conducting pharmacovigilance audits.
                        They have a unique combination of knowledge in the field of pharmacovigilance with the knowledge
                        of audits performance obtained during the trainings organized by MHRA, DIA, ISOP, BARQA and
                        during the postgraduate studies in "Quality Manager" completed with an auditor's certificate
                        issued by the Bureau Veritas (certification body) and the University of Business.
                    </h3>
                </div>
            </section>
            <section class="offer-3">
                <a class="anchor" id="offer-3-en"></a>
                <div class="offer-title">
                    <h2>MEDICAL INFORMATION</h2>
                </div>
                <div class="offer-content">
                    <h3>
                        ID Pharma prepares a medical information system adapted to the organizational structure of
                        the Marketing Authorization Holder, covering all markets where the MAH has authorized medicinal
                        products,
                        in particular preparing and managing the product reference information (Company Core Safety
                        Information)
                        as well as providing medical information in national languages in countries where medicinal
                        products
                        of the MAH are distributed.
                    </h3>
                </div>
            </section>
            <section class="offer-4">
                <a class="anchor" id="offer-4-en"></a>
                <div class="offer-title">
                    <h2>Local Contact Person in Poland and in other countries:</h2>
                </div>
                <div class="offer-content">
                    <h3>
                        ID Pharma represents the Marketing Authorization Holder in Poland,
                        providing support for pharmacovigilance processes and medical
                        information dedicated to the Polish market,
                    </h3>
                    <h3>
                        Ensuring compliance with Polish requirements, European regulations
                        and procedures of the Marketing Authorization Holder.
                    </h3>
                    <ul>
                        <li>
                            <h4>
                                acts as a local contact point for regulatory authorities ensuring the availability 24/7;
                            </h4>
                        </li>
                        <li>
                            <h4>
                                answers medical inquiries;
                            </h4>
                        </li>
                        <li>
                            <h4>
                                processes reports on adverse drug reactions in Poland.
                            </h4>
                        </li>
                    </ul>
                    <h4>
                        We cooperate with consultants / companies based in other EU and non-EU markets, providing 24/7
                        access to a person who provides medical information in the national
                        language and is included in the adverse drug reaction management system.
                    </h4>
                </div>
            </section>
            <section class="offer-5">
                <a class="anchor" id="offer-5-en"></a>
                <div class="offer-title">
                    <h2>
                        Cosmetovigilance
                    </h2>
                </div>
                <div class="offer-content">
                    <h3>
                        ID Pharma has its own cosmetovigilance system,
                        taking into account the latest legal requirements, which allows to
                        take over and fulfill the obligations on behalf of the manufacturer.
                    </h3>

                    <h3>
                        ID Pharma prepares, at the request of manufacturer, its own cosmetovigilance
                        system adjusted to the structure of the manufacturer`s organization
                        and provides 24-hour access, for evaluation and reporting of adverse effects.
                    </h3>
                </div>
            </section>
            <section class="offer-6">
                <a class="anchor" id="offer-6-en"></a>

                <div class="offer-title">
                    <h2>Registration of medicinal products:</h2>
                </div>
                <div class="offer-content">
                    <h3>
                        In the scope of our services, we offer cooperation:
                    </h3>
                    <ul>
                        <li>
                            <h4>
                                on planning the strategy and registration development of product / support in conducting
                                registration processes;
                            </h4>
                        </li>
                        <li>
                            <h4>
                                through support for national registration processes and post-authorization variations
                                (type
                                I and II variations, notifications);
                            </h4>
                        </li>
                        <li>
                            <h4>
                                through support in the processes of maintaining the validity of a marketing
                                authorizations
                                and their renewals;
                            </h4>
                        </li>
                        <li>
                            <h4>
                                on preparation of registration documentation;
                            </h4>
                        </li>
                        <li>
                            <h4>
                                in audits of the qualitative part of the registration documentation (Module 3+ Module
                                2.3);
                            </h4>
                        </li>
                        <li>
                            <h4>
                                by pharmacovigilance.
                            </h4>
                        </li>
                    </ul>

                </div>
            </section>
            <section class="contact">
                <a class="anchor" id="contact-en"></a>
                <div class="contact-logo">
                    <img src="images/logotyp.png" alt="logo" />
                </div>
                <div class="contact-content">
                    <ul class="contact-list">
                        <li>
                            <h2>Contact us:</h2>
                        </li>
                        <li>
                            <h2>
                                <a href="mailto:contact@idpharma.pl">contact@idpharma.pl</a>
                            </h2>
                        </li>
                        <li>
                            <h2>
                                <a href="tel:+48607696231">tel: (+48) 607 696 231</a>
                            </h2>
                        </li>
                        <li>
                            <h2>
                                <a href="tel:+48607696230">tel: (+48) 607 696 230</a>
                            </h2>
                        </li>
                    </ul>
                </div>
            </section>

            <footer class="footer" id="footer">
                <h4>
                    Copyright &copy;
                    <script>
                        document.write(new Date().getFullYear())
                    </script>
                </h4>
            </footer>
        </div>

    <script src="js/script.js" type="module"></script>
</body>

</html>